Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin et al
- PMID: 32895236
- DOI: 10.1136/annrheumdis-2020-218404
Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin et al
Keywords: autoimmune diseases; hydroxychloroquine; lupus erythematosus; systemic.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24. Ann Rheum Dis. 2020. PMID: 32332072 No abstract available.
-
Implications of SARS-CoV-2 infection for patients with rheumatic disease.Ann Rheum Dis. 2022 Aug;81(8):e152. doi: 10.1136/annrheumdis-2020-218050. Epub 2020 Aug 13. Ann Rheum Dis. 2022. PMID: 32792333 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous